TALEA Fundamental Analysis - TALEA GROUP SPA

Name: TALEA GROUP SPA (TALEA) Stock
Brand: TALEA GROUP SPA
Rating: 5 (3 reviews)

Fundamental Rating

We assign a fundamental rating of 2 out of 10 to TALEA. TALEA was compared to 21 industry peers in the Consumer Staples Distribution & Retail industry. Both the profitability and financial health of TALEA have multiple concerns. TALEA is not valued too expensively and it also shows a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

TALEA had negative earnings in the past year.

TALEA had a positive operating cash flow in the past year.

In the past 5 years TALEA always reported negative net income.

In multiple years TALEA reported negative operating cash flow during the last 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of -6.06%, TALEA is doing worse than 80.00% of the companies in the same industry.

The Return On Equity of TALEA (-29.09%) is worse than 84.00% of its industry peers.

		Industry Rank	Sector Rank
ROA	-6.06%
ROE	-29.09%
ROIC	N/A

ROA(3y)N/A

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

TALEA has a better Gross Margin (28.25%) than 80.00% of its industry peers.

TALEA's Gross Margin has declined in the last couple of years.

The Profit Margin and Operating Margin are not available for TALEA so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	28.25%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-30.82%

GM growth 5Y-3.93%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

TALEA does not have a ROIC to compare to the WACC, probably because it is not profitable.

TALEA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

TALEA has an Altman-Z score of 1.02. This is a bad value and indicates that TALEA is not financially healthy and even has some risk of bankruptcy.

TALEA has a worse Altman-Z score (1.02) than 96.00% of its industry peers.

TALEA has a Debt/Equity ratio of 0.73. This is a neutral value indicating TALEA is somewhat dependend on debt financing.

TALEA has a Debt to Equity ratio (0.73) which is in line with its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.73
Debt/FCF	N/A
Altman-Z	1.02

ROIC/WACCN/A

WACC5.99%

2.3 Liquidity

TALEA has a Current Ratio of 0.64. This is a bad value and indicates that TALEA is not financially healthy enough and could expect problems in meeting its short term obligations.

TALEA's Current ratio of 0.64 is on the low side compared to the rest of the industry. TALEA is outperformed by 84.00% of its industry peers.

A Quick Ratio of 0.27 indicates that TALEA may have some problems paying its short term obligations.

Looking at the Quick ratio, with a value of 0.27, TALEA is doing worse than 84.00% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	0.64
Quick Ratio	0.27

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

TALEA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 58.07%, which is quite impressive.

Looking at the last year, TALEA shows a decrease in Revenue. The Revenue has decreased by -3.10% in the last year.

The Revenue has been growing by 27.78% on average over the past years. This is a very strong growth!

EPS 1Y (TTM)58.07%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%81.2%

Revenue 1Y (TTM)-3.1%

Revenue growth 3Y15.59%

Revenue growth 5Y27.78%

Sales Q2Q%-17.38%

3.2 Future

The Earnings Per Share is expected to grow by 126.56% on average over the next years. This is a very strong growth

Based on estimates for the next years, TALEA will show a quite strong growth in Revenue. The Revenue will grow by 14.65% on average per year.

EPS Next Y263.31%

EPS Next 2Y126.56%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year19.99%

Revenue Next 2Y14.65%

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

TALEA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

A Price/Forward Earnings ratio of 11.51 indicates a reasonable valuation of TALEA.

TALEA's Price/Forward Earnings ratio is in line with the industry average.

Compared to an average S&P500 Price/Forward Earnings ratio of 32.73, TALEA is valued rather cheaply.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	11.51

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.

TALEA's earnings are expected to grow with 126.56% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y126.56%

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

TALEA does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

TALEA GROUP SPA

BIT:TALEA (8/5/2025, 7:00:00 PM)

4.8

+0.02 (+0.42%)

Chartmill FA Rating

GICS SectorConsumer Staples

GICS IndustryGroupConsumer Staples Distribution & Retail

GICS IndustryConsumer Staples Distribution & Retail

Earnings (Last)N/A N/A

Earnings (Next)N/A N/A

Inst Owners2.44%

Inst Owner ChangeN/A

Ins Owners48.13%

Ins Owner ChangeN/A

Market Cap40.80M

Revenue(TTM)127.40M

Net Income(TTM)-8.49M

Analysts86.67

Price Target10.2 (112.5%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)0%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)0%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	11.51
P/S	0.3
P/FCF	N/A
P/OCF	4.69
P/B	1.4
P/tB	N/A
EV/EBITDA	N/A

EPS(TTM)-0.46

EYN/A

EPS(NY)0.42

Fwd EY8.69%

FCF(TTM)-0.08

FCFYN/A

OCF(TTM)1.02

OCFY21.34%

SpS16.19

BVpS3.43

TBVpS-4.08

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-6.06%
ROE	-29.09%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	28.25%
FCFM	N/A

ROA(3y)N/A

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-30.82%

GM growth 5Y-3.93%

F-Score4

Asset Turnover0.98

Health

		Industry Rank	Sector Rank
Debt/Equity	0.73
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	202.09%
Cap/Sales	6.79%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	0.64
Quick Ratio	0.27
Altman-Z	1.02

F-Score4

WACC5.99%

ROIC/WACCN/A

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)58.07%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%81.2%

EPS Next Y263.31%

EPS Next 2Y126.56%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-3.1%

Revenue growth 3Y15.59%

Revenue growth 5Y27.78%

Sales Q2Q%-17.38%

Revenue Next Year19.99%

Revenue Next 2Y14.65%

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-683.35%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y94.14%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y242.23%

OCF growth 3YN/A

OCF growth 5YN/A

TALEA GROUP SPA / TALEA.MI FAQ

Can you provide the ChartMill fundamental rating for TALEA GROUP SPA?

ChartMill assigns a fundamental rating of 2 / 10 to TALEA.MI.

What is the valuation status for TALEA stock?

ChartMill assigns a valuation rating of 4 / 10 to TALEA GROUP SPA (TALEA.MI). This can be considered as Fairly Valued.

Can you provide the profitability details for TALEA GROUP SPA?

TALEA GROUP SPA (TALEA.MI) has a profitability rating of 1 / 10.

What is the earnings growth outlook for TALEA GROUP SPA?

The Earnings per Share (EPS) of TALEA GROUP SPA (TALEA.MI) is expected to grow by 263.31% in the next year.

TALEA GROUP SPA (TALEA.MI) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

TALEA GROUP SPA / TALEA.MI FAQ

Can you provide the ChartMill fundamental rating for TALEA GROUP SPA?

What is the valuation status for TALEA stock?

Can you provide the profitability details for TALEA GROUP SPA?

What is the earnings growth outlook for TALEA GROUP SPA?